7Baggers
 form 4 i mab for: 8 july by investing.com  Investing.com Nigeria Wed, 08 Jul 2026 21:02:21 GMT
 Form 4 I Mab For: 7 July By Investing.com  Investing.com Nigeria Wed, 08 Jul 2026 00:30:55 GMT
 form 4 i mab for: 30 june by investing.com  Investing.com Nigeria Tue, 30 Jun 2026 21:40:31 GMT
 form 4 i mab for: 24 june by investing.com  Investing.com Nigeria Wed, 24 Jun 2026 23:58:21 GMT
 form 4 i mab for: 22 june by investing.com  Investing.com Canada Mon, 22 Jun 2026 21:43:13 GMT
 i-mab (imab) institutional confidence  TradingKey Wed, 17 Jun 2026 09:33:05 GMT
 i-mab (imab) valuation: pe, pb & fair value analysis  TradingKey Wed, 17 Jun 2026 09:21:13 GMT
 i-mab prices $65m ads offering  MSN Mon, 08 Jun 2026 03:30:52 GMT
 China deals highlight biopharma evolution, reports LEK  BioWorld News Tue, 02 Jun 2026 07:00:00 GMT
 pfizer and i-mab forge $10.5 billion cancer drug development par  GuruFocus Fri, 29 May 2026 18:43:10 GMT
 nbp - novabridge biosciences adr stock price and quote  Finviz Wed, 27 May 2026 19:24:22 GMT
 tradingkey  TradingKey Tue, 12 May 2026 20:17:21 GMT
 i-mab regains compliance with nasdaq’s listing rule  MSN Tue, 28 Apr 2026 00:11:10 GMT
 i-mab regains compliance with nasdaq’s listing rule  MSN Mon, 27 Apr 2026 04:45:25 GMT
 i-mab regains compliance with nasdaq’s listing rule  MSN Sun, 26 Apr 2026 08:32:16 GMT
 i-mab prices $65m ads offering  MSN Fri, 24 Apr 2026 10:31:33 GMT
 i-mab prices $65m ads offering  MSN Thu, 23 Apr 2026 02:59:08 GMT
 i-mab biopharma shanghai co ltd  Reuters Mon, 20 Apr 2026 07:00:00 GMT
 i-mab regains compliance with nasdaq’s listing rule  MSN Thu, 16 Apr 2026 04:46:12 GMT
 i-mab regains compliance with nasdaq’s listing rule  MSN Wed, 15 Apr 2026 03:33:22 GMT
 i-mab (nasdaq:nbp) lowered to "sell" rating by wall street zen  MarketBeat Sat, 11 Apr 2026 06:00:34 GMT
 hc wainwright weighs in on i-mab's q1 earnings (nasdaq:nbp)  MarketBeat Fri, 10 Apr 2026 07:00:00 GMT
 i-mab (nasdaq:nbp) receives buy rating from hc wainwright  MarketBeat Wed, 08 Apr 2026 07:00:00 GMT
 i-mab stock: biotech innovator or high-risk bet?  AD HOC NEWS Fri, 03 Apr 2026 07:00:00 GMT
 i-mab (nbp) earnings date and reports 2026 $nbp  MarketBeat Wed, 01 Apr 2026 00:09:23 GMT
 i-mab reports third quarter 2024 results  GuruFocus Sun, 22 Mar 2026 23:06:02 GMT
 wall street zen downgrades i-mab (nasdaq:nbp) to hold  MarketBeat Sat, 21 Mar 2026 07:00:00 GMT
 hc wainwright reaffirms buy rating for i-mab (nasdaq:nbp)  MarketBeat Mon, 16 Mar 2026 07:00:00 GMT
 i-mab (nbp) fda approvals, pdufa dates & drug alerts 2026 $nbp  MarketBeat Mon, 09 Mar 2026 07:00:00 GMT
 imab sec filings - i-mab 10-k, 10-q, 8-k forms  Stock Titan Sun, 08 Mar 2026 04:23:28 GMT
 i-mab (nbp) fda approvals, pdufa dates & drug alerts 2026 $nbp  MarketBeat Tue, 03 Mar 2026 14:37:46 GMT
 i-mab (nasdaq:nbp) shares up 5.2% - still a buy?  MarketBeat Tue, 03 Mar 2026 08:00:00 GMT
 imab financials: income statement, balance sheet & cash flow  Stock Titan Sat, 28 Feb 2026 02:12:29 GMT
 i-mab’s pivotal year: clinical data to steer investor sentiment  AD HOC NEWS Mon, 09 Feb 2026 08:00:00 GMT
 hc wainwright forecasts i-mab's q1 earnings (nasdaq:nbp)  MarketBeat Mon, 09 Feb 2026 08:00:00 GMT
 i-mab (nasdaq:nbp) rating increased to buy at wall street zen  MarketBeat Sat, 07 Feb 2026 08:00:00 GMT
 i-mab (nbp) stock trends and sentiment 2026 $nbp  MarketBeat Fri, 06 Feb 2026 17:07:58 GMT
 i-mab (nbp) stock price, news & analysis $nbp  MarketBeat Fri, 06 Feb 2026 15:53:15 GMT
 i-mab (nbp) earnings date and reports 2026 $nbp  MarketBeat Fri, 06 Feb 2026 15:20:28 GMT
 I-Mab (NBP) Stock Forecast and Price Target 2026 $NBP  MarketBeat Fri, 06 Feb 2026 15:19:37 GMT
 i-mab shock move: why this sleeper biotech just crashed your feed  Ad-hoc-news.de Tue, 27 Jan 2026 08:00:00 GMT
 i-mab plans hong kong ipo and rebranding to novabridge biosciences  Intellectia AI Mon, 19 Jan 2026 06:17:11 GMT
 early-stage data for i-mab's uliledlimab at asco 22  The Pharma Letter Thu, 08 Jan 2026 15:09:41 GMT
 i-mab announces phase 1 data of givastomig at esmo 2023  GuruFocus Thu, 08 Jan 2026 02:06:18 GMT
 form 4 i mab for: 30 june by investing.com  Investing.com India Wed, 07 Jan 2026 08:00:00 GMT
 i-mab announces the appointment of raj kannan as ceo  Quantisnow Tue, 06 Jan 2026 19:24:17 GMT
 i-mab is suddenly everywhere: hidden gem stock or total trap?  AD HOC NEWS Tue, 06 Jan 2026 08:00:00 GMT
 published on: 2026-01-03 00:02:51  moha.gov.vn Fri, 02 Jan 2026 17:08:07 GMT
 published on: 2025-12-20 23:07:13  moha.gov.vn Sat, 20 Dec 2025 16:07:13 GMT
 what makes imab (imab) a new buy stock  MSN Fri, 12 Dec 2025 12:41:50 GMT

I-Mab
(NASDAQ:IMAB) 

IMAB stock logo

I-Mab, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel or highly differentiated biologics to treat diseases with unmet medical needs, primarily cancers and autoimmune disorders. It is developing Felzartamab (TJ202), a CD38 antibody th...

Founded: 2014
Full Time Employees: 229
CEO: Huaqiong Shen  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends